HIV Protease Inhibitors Inhibit the Development of Preerythrocytic-Stage Plasmodium Parasites
HIV Protease Inhibitors Inhibit the Development of Preerythrocytic-Stage Plasmodium Parasites
复制标题
DOI:
10.1086/594369
复制
发表时间:
2009-01-01
影响因子:
6.4
通讯作者:
Sinnis, Photini
中科院分区:
文献类型:
--
作者:
Hobbs, Charlotte V.;Voza, Tatiana;Sinnis, Photini
Recent studies have demonstrated that human immunodeficiency virus (HIV) protease inhibitors (PIs) exert inhibitory effects on erythrocytic stages of the human-malaria parasite Plasmodium falciparum in vitro and on erythrocytic stages of the rodent-malaria parasite Plasmodium chabaudi in vivo. Although it remains unclear how HIV PIs inhibit the parasite, the effect seen on parasite development in the erythrocytic stages is potent. The effect on preerythrocytic stages has not yet been investigated. Using the rodent parasite Plasmodium berghei, we screened a panel of HIV PIs in vitro for effects on the preerythrocytic stages. Our data indicated that the HIV PIs lopinavir and saquinavir affect preerythrocytic-stage parasite development in vitro. We then evaluated the effect of HIV PIs on preerythrocytic stages in vivo using the rodent parasite Plasmodium yoelii. We found that lopinavir/ritonavir had a dose-dependent effect on liver-stage parasite development. Given that sub-Saharan Africa is where the HIV/AIDS pandemic intersects with malaria, these results merit analysis in clinical settings.